[Porokeratosis in a patient with dermatomyositis].
There are several reports of porokeratosis in the context of immmunosuppressive diseases. These mainly include organ transplant, HIV infection, lymphomas and some inflammatory and autoimmune diseases commonly treated with immunosuppresive drugs or chemotherapy. Disseminated superficial actinic porokeratosis is the clinical variant of porokeratosis that most frequently develops in immunosuppressive states. We report a case of porokeratosis in a woman with dermatomyositis.
Monteagudo-Sánchez
B
B
Servicio de Dermatología, Complejo Hospitalario Arquitecto Marcide-Novoa Santos, Ferrol, La Coruña, Spain. benims@hotmail.com
Ginarte
M
M
Durana
C
C
Labandeira
J
J
de las Heras
C
C
Cacharrón
J M
JM
D000368:Aged; D003882:Dermatomyositis / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D017499:Porokeratosis / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D011241:Prednisone; D008727:Methotrexate